Practical Geriatrics ›› 2023, Vol. 37 ›› Issue (8): 806-810.doi: 10.3969/j.issn.1003-9198.2023.08.013
Previous Articles Next Articles
WANG Zhao-yang, ZHAO Li-na, LIANG Hao, CHEN Shu-xia, GU Jian
Received:
2022-10-14
Online:
2023-08-20
Published:
2023-08-28
Contact:
GU Jian, Email:gujian82023@163.com
CLC Number:
WANG Zhao-yang, ZHAO Li-na, LIANG Hao, CHEN Shu-xia, GU Jian. Predictive value of fibrinogen to albumin ratio on the severity of coronary lesions in elderly patients with suspected coronary artery disease[J]. Practical Geriatrics, 2023, 37(8): 806-810.
[1] 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021,36(6):521-545. [2] WANG W, LIU Y, LIU J, et al. Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: empirical evidence from national mortality surveillance system[J]. Int J Cardiol, 2021, 340:105-112. [3] CHEN X, LIN Y, TIAN L, et al. Correlation between ischemia-modified albumin level and coronary collateral circulation[J]. BMC Cardiovasc Disord, 2020, 20(1):326. [4] PANDRC M, RATKOVIĆ N, PERIĆ V, et al. Prevalence of traditional cardiovascular risk factors for coronary artery disease and elevated fibrinogen among active military personnel in Republic of Serbia: a cross-sectional study[J]. J Med Biochem, 2022,41(2):221-229. [5] WANG Y, XU W, WANG Y. Prognostic role of preoperative fibrinogen to albumin ratio in breast cancer[J]. Clin Chim Acta, 2020, 510:360-362. [6] LI B, DENG H, ZHOU Z, et al. The prognostic value of the fibrinogen to pre-albumin ratio in malignant tumors of the digestive system: a systematic review and meta-analysis[J]. Cancer Cell Int, 2022, 22(1):22. [7] LI M, TANG C, LUO E, et al. Relation of fibrinogen-to-albumin ratio to severity of coronary artery disease and long-term prognosis in patients with non-ST elevation acute coronary syndrome[J]. Biomed Res Int, 2020, 2020:1860268. [8] GENSINI G G. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol, 1983, 51(3):606. [9] HARRINGTON R A. Targeting inflammation in coronary artery disease[J]. N Engl J Med, 2017, 377(12):1197-1198. [10] KARAHAN O, ACET H, ERTAŞ F, et al. The relationship between fibrinogen to albumin ratio and severity of coronary artery disease in patients with STEMI[J]. Am J Emerg Med, 2016, 34(6):1037-1042. [11] CHEN T, SUN J L, ZHANG J. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting[J]. Coron Artery Dis, 2020, 31(7):586-589. [12] JENSEN T, KIERULF P, SANDSET P M, et al. Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells[J]. Thromb Haemost, 2007, 97(5):822-829. [13] SZABA F M, SMILEY S T. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo[J]. Blood, 2002, 99(3):1053-1059. [14] SONG B, SHU Y, XU Y N, et al. Plasma fibrinogen lever and risk of coronary heart disease among Chinese population: a systematic review and meta-analysis[J]. Int J Clin Exp Med, 2015, 8(8): 13195-13202. [15] ALEMAN M M, WALTON B L, BYRNES J R, et al. Fibrinogen and red blood cells in venous thrombosis[J]. Thromb Res, 2014,133 Suppl 1(01):S38-S40. [16] INDURUWA I, MOROI M, BONNA A, et al. Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation[J]. J Thromb Haemost, 2018,16(2):389-404. [17] ROCHE M, RONDEAU P, SINGH N R, et al. The antioxidant properties of serum albumin[J]. FEBS Lett, 2008,582(13):1783-1787. [18] PRAJAPATI K D, SHARMA S S, ROY N. Current perspectives on potential role of albumin in neuroprotection[J]. Rev Neurosci, 2011,22(3):355-363. [19] BARBANO B, GIGANTE A, AMOROSO A, et al. Thrombosis in nephrotic syndrome[J]. Semin Thromb Hemost, 2013,39(5):469-476. [20] HAMANAKA K, MIURA K, KOYAMA T, et al. The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer: a simple, economical, and effective biomarker[J]. J Thorac Dis, 2019,11(Suppl 3):S241-S244. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|